conv.

← The whole story
Health
Definium's LSD therapy clears second late-stage anxiety trial

Analyst calls results unusually consistent for neuropsych field

2 Sep 14 · 11d ago · 2 articles · 1 source · development 2 of 3

Evercore ISI analyst Gavin Clark-Gartner praised the three back-to-back successful trials as exceptional for the category, noting this consistency is atypical in neuropsychiatric drug development.

Analyst calls results unusually consistent for neuropsych field
Jerusalem Post

“It is really fascinating to see 3 back-to-back trials that show shockingly consistent benefits – this is just not something you normally see in the neuropsych field.”

Gavin Clark-Gartner

Definium Therapeutics Company developing DT120Robert Barrow CEO, Definium TherapeuticsGavin Clark-Gartner Analyst, Evercore ISI

The whole story articles the bright band is this development · numbered dots are the others · click one to jump

Peak 2 pieces in 3h at Sep 14, 9 AM; 8 pieces over 11 days (7 articles · 1 post) Sep 14, 6 AM — 1 piece · 1 article — Newswires 1Sep 14, 9 AM — 2 pieces · 2 articles — Newswires 2Sep 14, 12 PM — quietSep 14, 3 PM — 2 pieces · 2 articles — Google News 2Sep 14, 6 PM — quietSep 14, 9 PM — quietSep 15, 12 AM — quietSep 15, 3 AM — quietSep 15, 6 AM — 1 piece · 1 post — Reddit 1Sep 15, 9 AM — quietSep 15, 12 PM — quietSep 15, 3 PM — quietSep 15, 6 PM — quietSep 15, 9 PM — quietSep 16, 12 AM — quietSep 16, 3 AM — quietSep 16, 6 AM — quietSep 16, 9 AM — quietSep 16, 12 PM — 1 piece · 1 article — Newswires 1Sep 16, 3 PM — quietSep 16, 6 PM — quietSep 16, 9 PM — quietSep 17, 12 AM — quietSep 17, 3 AM — quietSep 17, 6 AM — quietSep 17, 9 AM — quietSep 17, 12 PM — quietSep 17, 3 PM — quietSep 17, 6 PM — quietSep 17, 9 PM — quietSep 18, 12 AM — quietSep 18, 3 AM — quietSep 18, 6 AM — quietSep 18, 9 AM — quietSep 18, 12 PM — quietSep 18, 3 PM — quietSep 18, 6 PM — quietSep 18, 9 PM — quietSep 19, 12 AM — quietSep 19, 3 AM — quietSep 19, 6 AM — quietSep 19, 9 AM — quietSep 19, 12 PM — quietSep 19, 3 PM — quietSep 19, 6 PM — quietSep 19, 9 PM — quietSep 20, 12 AM — quietSep 20, 3 AM — quietSep 20, 6 AM — quietSep 20, 9 AM — 1 piece · 1 article — Newswires 1Sep 20, 12 PM — quietSep 20, 3 PM — quietSep 20, 6 PM — quietSep 20, 9 PM — quietSep 21, 12 AM — quietSep 21, 3 AM — quietSep 21, 6 AM — quietSep 21, 9 AM — quietSep 21, 12 PM — quietSep 21, 3 PM — quietSep 21, 6 PM — quietSep 21, 9 PM — quietSep 22, 12 AM — quietSep 22, 3 AM — quietSep 22, 6 AM — quietSep 22, 9 AM — quietSep 22, 12 PM — quietSep 22, 3 PM — quietSep 22, 6 PM — quietSep 22, 9 PM — quietSep 23, 12 AM — quietSep 23, 3 AM — quietSep 23, 6 AM — quietSep 23, 9 AM — quietSep 23, 12 PM — quietSep 23, 3 PM — quietSep 23, 6 PM — quietSep 23, 9 PM — quietYesterday, 12 AM — quietYesterday, 3 AM — quietYesterday, 6 AM — quietYesterday, 9 AM — quietYesterday, 12 PM — quietYesterday, 3 PM — quietYesterday, 6 PM — quietYesterday, 9 PM — quietToday, 12 AM — quietToday, 3 AM — quietToday, 6 AM — quiet 1–3
1–3Analyst calls results unusually…
Sep 15Sep 16Sep 17Sep 18Sep 19Sep 20Sep 21Sep 22Sep 23now · 8:49 AM ET

Reported in the same hours no headline names this development itself — these 1 claim were published in its stretch

  1. 2 outlets Definium's LSD-based drug lowers anxiety in second successful late-stage study

    first by Jerusalem Post, 10d ago · also Seeking Alpha

    1 more headline

All 3 developments of Definium's LSD therapy clears second late-stage anxiety… →

NewswiresGoogle NewsReddit